PLANLINE / FIELD NOTES
Follow the source.
Explore the primary provider pages, public records and medical research cited by Planline’s original articles.
Provider pages support statements about published offers. They do not independently verify patient outcomes or service performance. Research papers and agency records are read within the product, population, date and claims they address.
Direct access to some BBB, Hers and Noom pages was restricted. Web retrieval and official indexed help material supplemented the research; current Noom checkout pricing is not asserted. Some client-rendered provider details were checked in a browser.
- CoreAge Rx official service informationget.coreagerx.com
- CoreAge Rx semaglutide product pagewww.coreagerx.com
- CoreAge Rx: current treatment optionswww.coreagerx.com
- FDA: concerns with unapproved GLP-1 drugswww.fda.gov
- BBB: current CoreAge Rx business profilewww.bbb.org
- SuperHealthy Rx official service informationwww.superhealthyrx.com
- Likeness Rx official service informationlikenessrx.com
- Ro official service informationro.co
- Hims official service informationwww.hims.com
- Hers official service informationwww.forhers.com
- WeightWatchers Clinic official service informationwww.weightwatchers.com
- Noom Med official service informationwww.noom.com
- Noom: telehealth for branded medicationswww.noom.com
- Noom: branded medication orders and shippingwww.noom.com
- Noom: branded prescriptions and pharmacywww.noom.com
- Form Health official service informationwww.formhealth.co
- Found official service informationjoinfound.com
- PlushCare official service informationplushcare.com
- Ivím Health official service informationwww.ivimhealth.com
- Fridays official service informationwww.joinfridays.com
- Remedy Meds official service informationremedymeds.com
- Henry Meds official service informationhenrymeds.com
- Mochi Health official service informationjoinmochi.com
- LifeMD official service informationlifemd.com
- MEDVi official service informationhome.medvi.org
- FDA: MEDVi letter, February 20, 2026www.fda.gov
- MEDVi: response dated April 8, 2026home.medvi.org
- OrderlyMeds official service informationmarketing.orderlymeds.com
- Eden official service informationwww.tryeden.com
- FDA: Eden letter, June 8, 2026www.fda.gov
- Amble official service informationjoinamble.com
- Enhance.MD official service informationenhance.md
- Zealthy official service informationgetzealthy.com
- ReflexMD official service informationwww.reflexmd.com
- ReflexMD cancellation helphelp.reflexmd.com
- Sesame official service informationsesamecare.com
- WeightCare official service informationjoinweightcare.com
- FuturHealth official service informationlanding.fh.co
- TrimRx official service informationtrimrx.com
- Gala official service informationgalaglp1.com
- Levity official service informationwww.joinlevity.com
- STEP 1 trial extension: weight regain after semaglutide withdrawalpubmed.ncbi.nlm.nih.gov
- SURMOUNT-4: continued tirzepatide versus withdrawalpubmed.ncbi.nlm.nih.gov
- NIDDK: prescription medications for overweight and obesitywww.niddk.nih.gov
- CoreAge Rx: refill check-inshelp.coreagerx.com
- CoreAge Rx: doctor messaginghelp.coreagerx.com
- FDA: concerns with unapproved GLP-1 drugswww.fda.gov
- CoreAge Rx Help Center: about the servicehelp.coreagerx.com
- FDA: compounding questions and answerswww.fda.gov